Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages

International Journal of Health Geographics

Volumn 9, Issue , 2010, Pages

  Janies, Daniel A ^a   Voronkin, Igor O ^a   Studer, Jonathon ^a   Hardman, Jori ^a   Alexandrov, Boyan B ^a   Treseder, Travis W ^a   Valson, Chandni ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE RESISTANCE; DISEASE TREATMENT; INFLUENZA; MUTATION; WORLD HEALTH ORGANIZATION;

ANTIVIRUS AGENT; OSELTAMIVIR; SIALIDASE;

ANTIVIRAL RESISTANCE; ARTICLE; CLUSTER ANALYSIS; COMMUNICABLE DISEASE; DRUG ANTAGONISM; ENZYMOLOGY; EPIDEMIC; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; PHYLOGENY; VIROLOGY;

ANTIVIRAL AGENTS; CLUSTER ANALYSIS; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NEURAMINIDASE; OSELTAMIVIR; PHYLOGENY;

EID: 77951157023     PISSN: None     EISSN: 1476072X     Source Type: Journal    
DOI: 10.1186/1476-072X-9-13     Document Type: Article

References (24)

1. WHO Pandemic (H1N1) 2009 - update 58. 2009, WHO., http://www.who.int/csr/don/2009_07_06/en/index.html
2. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 2009, 2657637, 19193257.
3. Hurt AC, Ernesta J, Denga Y, Iannelloa P, Besselaarc T, et al. Emergence and spread of oseltamivir-resistant A (H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Research 2009, 83:90-93. 10.1016/j.antiviral.2009.03.003, 19501261.
4. WHO "Pandemic (H1N1) 2009 - update 83". WHO., http://www.who.int/csr/disease/swineflu/laboratory15_01_2010/en/index.html
5. CDC Oseltamivir-Resistant Novel Influenza A (H1N1) Virus Infection in Two Immunosuppressed Patients - Seattle, Washington, 2009. CDC., http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58d0814a1.htm
6. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin M, Boivin M. Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis. NEJM 2009, 361:2296-2297. 10.1056/NEJMc0910060, 19907034.
7. Hill A, Guralnick R, Wilson M, Habib F, Janies D. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infection, Genetics, and Evolution 2009, 9:169-178.
8. Sheu T, Deyde V, Okomo-Adhiambo M, Garten R, Xu X, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrobial Agents and Chemotherapy 2008, 52:3284-92. 10.1128/AAC.00555-08, 2533500, 18625765.
9. Hurt A, Holien J, Parker M, Kelso A, Barr I. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. Journal of Virology 2009, 83:10366-10373. 10.1128/JVI.01200-09, 19641000.
10. Monto A, McKimm-Breschkin J, Macken C, Hampson A, Hay A, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrobial Agents and Chemotherapy 2006, 50:2395-2402. 10.1128/AAC.01339-05, 1489772, 16801417.
11. Kosakovsky Pond S, Frost S, Muse S. HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21:676-679. 10.1093/bioinformatics/bti079, 15509596.
12. Hauge S, Blix H, Borgen K, Hungnes O, Dudman S, Aavitsland P. Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A (H1N1) viruses in 2007-08. Virology Journal 2009, 6:54. 10.1186/1743-422X-6-54, 2685787, 19435505.
13. "Healthy people with swine flu should not be given Tamiflu, says WHO". , http://www.telegraph.co.uk/health/swine-flu/6066444/Healthy-people-with-swine-flu-should-not-be-given-Tamiflu-says-WHO.html
14. F. Hoffmann-La Roche Ltd "Further expansion of Tamiflu manufacturing capacity". F. Hoffmann-La Roche Ltd., http://www.roche.com/med-cor-2005-10-18
15. Simonsen L, Viboud C, Grenfell B, Dushoff J, Jennings L, et al. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring Adamantane resistance. Mol Bio & Evol 2007, 24:1811-1820.
16. Maurer-Stroh S, Ma J, Tze Chuen Lee R, Sirota F, Eisenhaber F. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. Biology Direct 2009, 4:18. 10.1186/1745-6150-4-18, 2691737, 19457254.
17. CDC "Map: International Co-circulation of 2009 H1N1 and Seasonal Influenza (Week of January 17-23, 2010)". , http://www.cdc.gov/h1n1flu/updates/international/map.htm
18. Perez D, Sorrell E, Angel M, Ye J, Hickman D, Pena L, Ramirez-Nieto G, Kimble B, Araya Y. Fitness of Pandemic H1N1 and Seasonal influenza A viruses during Co-infection: Evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. Version 2. PLoS Curr Influenza. 2009 August 25 [revised 2009 August 27]: RRN1011 , http://www.ncbi.nlm.nih.gov/rrn/RRN1011
19. Wu J, Leung G, Lipsitch M, Cooper B, Riley S. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Medicine 2009, 6:5.
20. Shay D, Ridenhour B. Can We "Hedge" against the development of antiviral resistance among pandemic influenza viruses?. PLoS Medicine 2009, 6:6.
21. Kuo-Bin L. ClustalW-MPI: ClustalW analysis using distributed and parallel computing. Bioinformatics 2003, 19:1585-1586. 10.1093/bioinformatics/btg192, 12912844.
22. Posada D. ModelTest Server: a web-based tool for the statistical selection of models of nucleotide substitution online. Nucleic Acids Research 2006, 34:W700-W703. 10.1093/nar/gkl042, 1538795, 16845102.
23. Swofford D. PAUP*: phylogenetic analysis using parsimony (* and other methods). 2002, Sinauer, Sunderland, MA.
24. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 2006, 22:2688-2690. 10.1093/bioinformatics/btl446, 16928733.